Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 4/20 | 0.50 |
| ▸ | DDO | Q99489 | 3/20 | 0.50 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.43 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RHEB | Q15382 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CTSV | O60911 | 2/20 | 0.36 |
| ▸ | CTSL | P07711 | 2/20 | 0.36 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8088130 | 0.86 | CTSV (0.44) | DAODDOIMPDH2IMPDH1PARP1 | |
| SCHEMBL5768535 | 0.83 | RHEB (0.51) | DAODDOIMPDH2IMPDH1HRH4 | |
| SCHEMBL28352953 | 0.81 | IMPDH2 (0.43) | DAODDOIMPDH2IMPDH1HRH4 | |
| SCHEMBL9587971 | 0.81 | ASH1L (0.44) | DAODDOIMPDH2IMPDH1HRH4 | |
| SCHEMBL20125059 | 0.79 | DAO (0.60) | DAODDOPARP1MTNR1AMTNR1B | |
| SCHEMBL5771112 | 0.79 | HTR1A (0.51) | DAODDOIMPDH2IMPDH1HRH4 | |
| SCHEMBL30120739 | 0.79 | HTR2C (0.45) | DAODDOIMPDH2IMPDH1HRH4 | |
| SCHEMBL23714709 | 0.78 | PARP1 (0.42) | DAODDOPARP1HRH4MTNR1A | |
| SCHEMBL17345632 | 0.78 | DAO (0.49) | DAODDOPARP1HRH4MTNR1A | |
| SCHEMBL5917425 | 0.78 | DAO (0.49) | DAODDOPARP1HRH4MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220400673-A1 | METHODS FOR WEED GROWTH CONTROL | Mustgrow Biologics Corp. (CA) | 2022-12-22 | — | — | US | disclosed |
| WO-2022109755-A1 | METHODS FOR CONTROLLING FUSARIUM WILT OF BANANA PLANTS | Mustgrow Biologics Corp. (CA) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022082311-A1 | METHODS AND COMPOSITIONS COMPRISING HERBICIDALLY ACTIVE COMPOUNDS AND THIOCYANATE COMPOUNDS FOR CONTROLLING WEED GROWTH | Mustgrow Biologics Corp. (CA) | 2022-04-28 | — | — | WO | disclosed |
| WO-2021077214-A1 | METHODS FOR WEED GROWTH CONTROL | Mustgrow Biologics Corp. (CA) | 2021-04-29 | — | — | WO | disclosed |
| WO-2018069863-A1 | 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-04-19 | — | — | WO | disclosed |
| CN-101838232-B | Preparation method for varespladib | AISI MEDICAL TECHNOLOGY (NANJING) CO., LTD. (CN) | 2012-02-22 | — | — | CN | disclosed |
| CN-101838232-A | Preparation method for varespladib | ACESYS PHARMATECH NANJING CO LTD | 2010-09-22 | — | — | CN | disclosed |
| EP-1509515-A4 | SUBSTITUTED 4-ARYL-4H-PYRROLO 2,3-H CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA INC (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1509515-A2 | SUBSTITUTED 4-ARYL-4H-PYRROLO 2,3-H CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | Cytovia, Inc. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003097806-A2 | SUBSTITUTED 4-ARYL-4H-PYRROLO[2,3-H]CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2003-11-27 | — | — | WO | disclosed |
| CN-1067054-C | 1H-indole-3-glyoxylamide spla2 inhibitors | LILLY CO ELI (US) | 2001-06-13 | — | — | CN | disclosed |
| WO-2000061554-A1 | 1-AMINO ETHYLINDOLE DERIVATIVES FOR THE TREATMENT OF URINARY INCONTINENCE | SANOFI-SYNTHELABO (FR) | 2000-10-19 | — | — | WO | disclosed |
| WO-2000061553-A1 | 2-AMINOETHYL-INDOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE | SANOFI-SYNTHELABO (FR) | 2000-10-19 | — | — | WO | disclosed |
| US-5254595-A | Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them | ELF SANOFI (FR) | 1993-10-19 | — | — | US | disclosed |
| EP-0375560-B1 | ARYLOXYPROPANOLAMINOTETRALINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | ELF SANOFI (FR) | 1993-05-12 | — | — | EP | disclosed |
| EP-0375560-A1 | Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same | ELF SANOFI (FR) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220400673-A1 | METHODS FOR WEED GROWTH CONTROL | TST, NOTUM, GLO1 | DAO 602/4885DDO 1574/4885IMPDH2 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.